LexDanaLexDanabeta
Inventor

JOHN M. MCCALL

Inventor
US

Overview

11→
Patents
2021–2023
Patent span
Chemistry
Primary field (CPC C)

Patents· 11 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds23%
C07CAcyclic or carbocyclic compounds15%
C07BGeneral methods of organic chemistry10%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C07JSteroids3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
11,833,159Non-hormonal steroid modulators of NF-kB for treatment of disease202311,773,068KDM1A inhibitors for the treatment of disease202311,771,684Inhibitors of dihydroceramide desaturase for treating disease202311,690,853Non-hormonal steroid modulators of NF-kb for treatment of disease202311,661,409Acid addition salts, compositions, and methods of treating202311,655,226KDM1A inhibitors for the treatment of disease202311,479,541Acid addition salts, compositions, and methods of treating thereof202211,459,307Heterocyclic compounds for the inhibition of PASK202211,390,590Methods and processes for the preparation of KDM1A inhibitors202211,230,534KDM1A inhibitors for the treatment of disease202211,135,207Inhibitors of dihydroceramide desaturase for treating disease2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2023Patents assigned to CENTAURUS THERAPEUTICS (2)· patent assignee history
2021–2023Based in US· patent location history
2022–2023Patents assigned to IMAGO BIOSCIENCES INC (4)· patent assignee history
2022–2023Patents assigned to PIONEURA CORP (2)· patent assignee history
2022Patents assigned to BIOENERGENIX LLC (1)· patent assignee history
2023Patents assigned to REVERAGEN BIOPHARMA INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IMAGO BIOSCIENCES INC42022–2023
CENTAURUS THERAPEUTICS22021–2023
PIONEURA CORP22022–2023
REVERAGEN BIOPHARMA INC22023
BIOENERGENIX LLC12022
Locations
LocationPatentsSpan
US112021–2023